Silverfin false false 31/01/2026 01/02/2025 31/01/2026 C J Shearer 24/10/2023 11 May 2026 The principal activity of the Company during the financial year was the provision of medical services. SC786939 2026-01-31 SC786939 bus:Director1 2026-01-31 SC786939 2025-01-31 SC786939 core:CurrentFinancialInstruments 2026-01-31 SC786939 core:CurrentFinancialInstruments 2025-01-31 SC786939 core:ShareCapital 2026-01-31 SC786939 core:ShareCapital 2025-01-31 SC786939 core:RetainedEarningsAccumulatedLosses 2026-01-31 SC786939 core:RetainedEarningsAccumulatedLosses 2025-01-31 SC786939 core:FurnitureFittings 2025-01-31 SC786939 core:ComputerEquipment 2025-01-31 SC786939 core:FurnitureFittings 2026-01-31 SC786939 core:ComputerEquipment 2026-01-31 SC786939 core:FurtherRelatedPartyRelationshipType2ComponentAllOtherRelatedParties core:CurrentFinancialInstruments 2026-01-31 SC786939 core:FurtherRelatedPartyRelationshipType2ComponentAllOtherRelatedParties core:CurrentFinancialInstruments 2025-01-31 SC786939 bus:OrdinaryShareClass1 2026-01-31 SC786939 2025-02-01 2026-01-31 SC786939 bus:FilletedAccounts 2025-02-01 2026-01-31 SC786939 bus:SmallEntities 2025-02-01 2026-01-31 SC786939 bus:AuditExemptWithAccountantsReport 2025-02-01 2026-01-31 SC786939 bus:PrivateLimitedCompanyLtd 2025-02-01 2026-01-31 SC786939 bus:Director1 2025-02-01 2026-01-31 SC786939 core:FurnitureFittings core:TopRangeValue 2025-02-01 2026-01-31 SC786939 core:ComputerEquipment core:TopRangeValue 2025-02-01 2026-01-31 SC786939 2023-10-24 2025-01-31 SC786939 core:FurnitureFittings 2025-02-01 2026-01-31 SC786939 core:ComputerEquipment 2025-02-01 2026-01-31 SC786939 bus:OrdinaryShareClass1 2025-02-01 2026-01-31 SC786939 bus:OrdinaryShareClass1 2023-10-24 2025-01-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: SC786939 (Scotland)

# CJSURGICAL LIMITED

### UNAUDITED FINANCIAL STATEMENTS
FOR THE FINANCIAL YEAR ENDED 31 JANUARY 2026
PAGES FOR FILING WITH THE REGISTRAR

CJSURGICAL LIMITED

## UNAUDITED FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 JANUARY 2026

Contents

CJSURGICAL LIMITED

## BALANCE SHEET

AS AT 31 JANUARY 2026
CJSURGICAL LIMITED

## BALANCE SHEET (continued)

AS AT 31 JANUARY 2026

| Note | 31.01.2026 |  | 31.01.2025
|  | £ |  | £
Fixed assets |  |  |  |
Tangible assets | 3 | 1,339 |  | 1,785
|  | 1,339 |  | 1,785
Current assets |  |  |  |
Debtors | 4 | 178,311 |  | 99,993
Cash at bank and in hand |  | 3,000 |  | 6,375
|  | 181,311 |  | 106,368
Creditors: amounts falling due within one year | 5 | ( 114,165) |  | ( 97,865)
Net current assets |  | 67,146 |  | 8,503
Total assets less current liabilities |  | 68,485 |  | 10,288
Provision for liabilities | 6 | ( 335) |  | ( 446)
Net assets |  | 68,150 |  | 9,842
Capital and reserves |  |  |  |
Called-up share capital | 7 | 100 |  | 100
Profit and loss account |  | 68,050 |  | 9,742
Total shareholder's funds |  | 68,150 |  | 9,842

For the financial year ending 31 January 2026 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

- The member has not required the Company to obtain an audit of its financial statements for the financial year in accordance with section 476;
- The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements; and
- These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime and a copy of the Profit and Loss Account has not been delivered.

The financial statements of CJSurgical Limited (registered number: SC786939) were approved and authorised for issue by the Director on 11 May 2026. They were signed on its behalf by:

C J Shearer Director |

CJSURGICAL LIMITED

## NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 JANUARY 2026
CJSURGICAL LIMITED

## NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 JANUARY 2026

##### 1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial period, unless otherwise stated.

##### General information and basis of accounting

CJSurgical Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in Scotland. The address of the Company's registered office is C/O Johnston Carmichael Unit 2a, The Paddock, Stirling Agricultural Centre, Stirling, FK9 4RN, Scotland, United Kingdom.
The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.
The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

##### Going concern

The director has assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The director has a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

##### Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.
Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.

##### Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.
Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.
The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

##### Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Fixtures and fittings | 5 years straight line
Computer equipment | 3 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

##### Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.
Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Financial assets are derecognised when and only when the contractual rights to the cash flows from the financial asset expire or are settled, or the Company transfers to another party substantially all of the risks and rewards of ownership of the financial asset, or the Company, despite having retained some, but not all, significant risks and rewards of ownership, has transferred control of the asset to another party.

Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

##### Provisions

Provisions are recognised when the Company has a present obligation (legal or constructive) as a result of a past event, it is probable that the Company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.
The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the Balance Sheet date, taking into account the risks and uncertainties surrounding the obligation. Where a provision is measured using the cash flows estimated to settle the present obligation, its carrying amount is the present value of those cash flows (when the effect of the time value of money is material).
When some or all of the economic benefits required to settle a provision are expected to be recovered from a third party, a receivable is recognised as an asset if it is virtually certain that reimbursement will be received and the amount of the receivable can be measured reliably.

#### 2. Employees

| Year ended 31.01.2026 |  | Period from 24.10.2023 to 31.01.2025
| Number |  | Number
Monthly average number of persons employed by the Company during the year, including the director | 1 |  | 1

#### 3. Tangible assets

| Fixtures and fittings |  | Computer equipment |  | Total
| £ |  | £ |  | £
Cost |  |  |  |  |
At 01 February 2025 | 2,231 |  | 1,500 |  | 3,731
At 31 January 2026 | 2,231 |  | 1,500 |  | 3,731
Accumulated depreciation |  |  |  |  |
At 01 February 2025 | 446 |  | 1,500 |  | 1,946
Charge for the financial year | 446 |  | 0 |  | 446
At 31 January 2026 | 892 |  | 1,500 |  | 2,392
Net book value |  |  |  |  |
At 31 January 2026 | 1,339 |  | 0 |  | 1,339
At 31 January 2025 | 1,785 |  | 0 |  | 1,785

#### 4. Debtors

| 31.01.2026 |  | 31.01.2025
| £ |  | £
Amounts owed by connected companies | 27,036 |  | 29,523
Other debtors | 151,275 |  | 70,470
| 178,311 |  | 99,993

#### 5. Creditors: amounts falling due within one year

| 31.01.2026 |  | 31.01.2025
| £ |  | £
Accruals | 4,500 |  | 4,320
Taxation and social security | 109,665 |  | 93,545
| 114,165 |  | 97,865

#### 6. Provision for liabilities

| 31.01.2026 |  | 31.01.2025
| £ |  | £
Deferred tax | 335 |  | 446

#### 7. Called-up share capital

| 31.01.2026 |  | 31.01.2025
| £ |  | £
Allotted, called-up and fully-paid |  |  |
100 Ordinary shares of £ 1.00 each | 100 |  | 100

#### 8. Related party transactions

Transactions with the entity's director

| 31.01.2026 |  | 31.01.2025
| £ |  | £
Amounts owed by the director | 151,275 |  | 70,470

Interest has been charged at a rate of between 2.25%-3.75% out outstanding amounts. Amounts are unsecured, and there are no fixed repayment terms

Other related party transactions

| 31.01.2026 |  | 31.01.2025
| £ |  | £
Amounts due from associated company | 27,036 |  | 29,523

The above amount is unsecured, interest-free, and there are no fixed repayment terms.